Repligen Corporation (Repligen) is a biopharmaceutical company focused on the development of novel therapeutics primarily for the treatment of diseases of the central nervous system. Repligen is developing novel therapeutics primarily for radiology and neuropsychiatry. A number of drug development programs are being conducted to evaluate the Company's drug candidates in diseases, such as pancreatitis, bipolar disorder and neurodegeneration. In addition, Repligen sells a line of products based on Protein A for monoclonal antibody purification.
There are no scholarships at this time
There are no events at this time
Company Data on
Repligen Corporation is hiring for these positions